Novo Nordisk A/S said on 16th August 2017,its diabetes drug met the main goal of reducing glucose levels in patients in a key late-stage trial, setting the stage for it to become the new standard therapy for type 2 diabetes.The 40-week trial tested two dosages of Novo's once-weekly drug, semaglutide, in addition to initial standard-of-care therapy metformin, against Eli Lilly and Co's dulaglutide plus metformin.
SEE THE REPORT-in link...
Finally Good News For Diabetes.
Mechanism of action of metformin,most widely used anti hyperglycaemic drug.
Is LCHF good in High Blood Presser and Diabetes? Some says LCHF is not good in High BP.
